# Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects

> **NCT00808119** · PHASE1 · COMPLETED · sponsor: **RTI International** · enrollment: 30 (estimated)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** RTI-336 (CTDP 31862)

## Key facts

- **NCT ID:** NCT00808119
- **Lead sponsor:** RTI International
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00808119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00808119, "Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00808119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*